Incidence of venous thromboembolism in hospitalized patients vs community residents

Mayo Clinic Proceedings

Volumn 76, Issue 11, 2001, Pages 1102-1110

  Heit, John A ^a   Melton, L Joseph ^a   Lohse, Christine M ^a   Petterson, Tanya M ^a   Silverstein, Marc D ^a,b   Mohr, David N ^a   O’fallon, W Michael ^a  

^a MAYO CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CI = confidence interval; DVT = deep venous thrombosis; PE = pulmonary embolism

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMMUNITY; DEEP VEIN THROMBOSIS; EMBOLISM PREVENTION; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; THROMBOEMBOLISM;

EID: 0034764121     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.11.1102     Document Type: Article

References (50)

1. Prevention of venous thromboembolism
2. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement: A randomized, doubleblind, placebo-controlled trial
3. Venous thromboembolism and other venous disease in the Tecumseh community health study
4. Incidence of acute deep vein thrombosis in two districts: A phlebographic study
5. Hospitalization and case fatality for pulmonary embolism in the Twin Cities: 1979-1984
6. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT study
7. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California
8. Hospital admission and mortality rates for venous thromboembolism in Oxford region, UK, 1975-98
9. History of the Rochester epidemiology project
10. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study
11. Calculating Incidence, Prevalence and Mortality Rates for Olmsted County, Minnesota: An Update
12. A prospective study of the incidence of deep-vein thrombosis within a defined urban population
13. Pulmonary embolism and thrombophlebitis in the United States, 1970-1985
14. Deep vein thrombosis and pulmonary embolism in the general population: "The Study of Men Born in 1913."
15. High risk of the critically ill for venous thromboembolism
16. Epidemiology of oral contraceptives and cardiovascular disease
17. Incidence and diagnosis of deep vein thrombosis associated with pregnancy
18. Risk factors for pregnancy associated venous thromboembolism
19. Physician practices in the prevention of venous thromboembolism
20. Underuse of venous thromboembolism prophylaxis for general surgery patients: Physician practices in the community hospital setting
21. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Overview of results of randomized trials in general, orthopedic, and urologic surgery
22. Prevention of venous thromboembolism in internal medicine with unfractionated heparin or low-molecular-weight heparins: A meta-analysis of randomised clinical trials
23. Death and thromboembolic disease after total hip replacement: A series of 1162 cases with no routine chemical prophylaxis
24. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation
25. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: A multiinstitutional cohort study of patients who underwent hip or knee arthroplasty
26. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
27. Heparin prophylaxis in bedridden patients
28. Heparin prophylaxis for medical patients?
29. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee - A prospective study
30. Applying risk assessment models in non-surgical patients: Overview of our clinical experience
31. Prevention of venous thromboembolism: Adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients
32. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty: Evaluation during hospitalization and three months after discharge
33. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty
34. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study
35. Undiagnosed diseases in an aging population: Pulmonary embolism and bronchopneumonia
36. Autopsy study of the elderly institutionalized patient: Review of 234 autopsies
37. An anatomy of the autopsy, Olmsted County, 1935 through 1985, Mayo Clin Proc
38. Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based cohort study
39. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: A population-based study
40. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients
41. Risk of venous thromboembolism in users of hormone replacement therapy
42. Prospective study of exogenous hormones and risk of pulmonary embolism in women
43. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
44. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
45. Mutation in blood coagulation factor V associated with resistance to activated protein C
46. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
47. Anticardiolipin anti-bodies and the risk for ischemic stroke and venous thrombosis
48. Increased risk of venous thrombosis in oral-contra-ceptive users who are carriers of factor V Leiden mutation